Back to search results

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

AML, Childhood · Aml · Acute Myeloid Leukemia, Pediatric · Acute Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Thomas M Pfeiffer, M.D.) · pthomas@wustl.edu · 314-273-2070
    Contact: Principal Investigator (Thomas M Pfeiffer, M.D.)
    Amanda Cashen, M.D. (Sub-investigator)
    Todd Fehniger, M.D., Ph.D. (Sub-investigator)
    Shalini Shenoy, M.D. (Sub-investigator)
    Robert Hayashi, M.D. (Sub-investigator)
    Melissa Mavers, M.D., Ph.D. (Sub-investigator)
    Rachel Langley, PharmD (Sub-investigator)
    Feng Gao, Ph.D. (Sub-investigator)
Study leads

  • Thomas M Pfeiffer, M.D.

    Principal Investigator

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)